Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 19, 2024 - Issue
Submit an article Journal homepage
104
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Are There Significant Differences Between Hospitalized and Emergency Department Patients?

Mathieu D Saint-Pierre1 University of Ottawa, Faculty of Medicine, Ottawa, ON, Canada;2 Institut du Savoir Montfort, Ottawa, ON, Canada;3 Montfort Hospital, Division of Respirology, Ottawa, ON, CanadaCorrespondence[email protected]
View further author information
Pages 133-138 | Received 07 Nov 2023, Accepted 10 Jan 2024, Published online: 15 Jan 2024

References

  • Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(6):596–601. doi:10.1164/rccm.201211-2044OC
  • Canadian Institute for Health Information. Hospital stays in Canada report; 2020.
  • Amegadzie JE, Lee TY, Sadatsafavi M, Lynd LD, Sin DD, Johnson KM. Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada. Can Med Ass J. 2023;195(35):E1172–E1179.
  • Canadian Lung Association. Pre-budget consultations house of commons; 2011.
  • Global initiative for chronic obstructive lung disease 2023 report. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed October 10, 2023.
  • Bourbeau J, Bhutani M, Hernandez P, et al. Canadian thoracic society clinical practice guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Can J Respir Crit Care Sleep Med. 2019;3:210–232. doi:10.1080/24745332.2019.1668652
  • Bourbeau J, Bhutani M, Hernandez P, et al. 2023 Canadian thoracic society guideline on pharmacotherapy in patients with stable COPD. Can J Respir Crit Care Sleep Med. 2023;7:173–191. doi:10.1080/24745332.2023.2231451
  • Wedzicha JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013;11(1):181. doi:10.1186/1741-7015-11-181
  • Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–1303. doi:10.1164/rccm.200310-1443OC
  • Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(3):324–330. doi:10.1164/rccm.201605-1014OC
  • Watz H, Tetzlaff K, Magnussen H, et al. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respir Res. 2018;19(1):251. doi:10.1186/s12931-018-0944-3
  • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. New Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
  • Soler-Cataluña JJ, Martínez-García MÁ, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
  • Ho TW, Tsai YJ, Ruan SY, Huang CT, Lai F, Yu CJ. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study. PLoS One. 2014;9(12):e114866. doi:10.1371/journal.pone.0114866
  • Mittmann N, Kuramoto L, Seung S, Haddon J, Bradley-Kennedy C, FitzGerald J. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102(3):413–421. doi:10.1016/j.rmed.2007.10.010
  • Hasegawa K, Tsugawa Y, Tsai CL, Brown DF, Camargo J. Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease. Respir Res. 2014;15(1):40. doi:10.1186/1465-9921-15-40
  • Rowe BH, Cydulka RK, Tsai CL, Clark S, Sinclair D, Camargo J. Comparison of Canadian versus United States emergency department visits for chronic obstructive pulmonary disease exacerbation. Canad Resp J. 2008;15(6):295–301. doi:10.1155/2008/696482
  • Payne E. Up to 150,000 Ottawa residents don’t have access to primary care: Ottawa public health. Ottawa Citizen. 2023;2023:1.
  • Tsai CL, Griswold SK, Clark S, Camargo CA. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med. 2007;22(6):799–804. doi:10.1007/s11606-007-0191-7
  • Lipson DA, Barnhart F, Brealey N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. New Engl J Med. 2018;378(18):1671–1680. doi:10.1056/NEJMoa1713901
  • Papi A, Vestbo J, Fabbri L, et al. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet. 2018;391(10125):1076–1084. doi:10.1016/S0140-6736(18)30206-X
  • Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;383(1):35–48. doi:10.1056/NEJMoa1916046
  • Celli BR, Fabbri LM, Aaron SD, et al. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med. 2021;204(11):1251–1258. doi:10.1164/rccm.202108-1819PP

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.